For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated ...

MUSC research to use he immune system to fight cancer shows it can be done safer, cheaper and better. An SC company pushing ...

Nivolumab plus ipilimumab did not improve OS vs chemotherapy in patients with previously untreated, unresectable/metastatic urothelial carcinoma.

Cervical cancer prevention advances with new immunotherapy findings, addressing disparities and improving outcomes for ...

Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...

Artificial intelligence (AI) technologies and machine learning (ML) algorithms are witnessing tremendous growth in immunology ...

A phase 2 trial shows promising results for pembrolizumab combined with cisplatin and radiation in treating unresectable ...

Investigators studied the effect of immunotherapy on overall survival among women with genital tract melanoma.

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...